nach oben

memo - Magazine of European Medical Oncology

Inhalt (13 Artikel)

editorial

Welcome to the new associate Editor-in-Chief of memo

Wolfgang Hilbe, Waltraud Radlherr

editorial

A welcome statement from the associate Editor-in-Chief

Rupert Bartsch

editorial

ASH 2015—insights and outlooks

Niklas Zojer

editorial

Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma

Wolfgang Hilbe, Rupert Bartsch, Christoph Zielinski

special report

Novel strategies in the management of chronic lymphocytic leukemia (CLL)

Daniel Heintel

short review

Acute myeloid leukemia: highlights from ASH 2015

Michael Pfeilstöcker

short review

Indolent lymphoma at ASH 2015: new treatment approaches

Thomas Nösslinger

short review

Practice changing information in aggressive lymphoma, ASH 2015

Michael A. Fridrik

short review

Focus on multiple myeloma at ASH 2015

Niklas Zojer

Open Access short review

Reversal of direct oral anticoagulants in hemophilia treatment

Clemens Feistritzer, Stefan Schmidt

short review

ASH 2015 – stem cell transplantation

Johannes Clausen

Open Access short review

Antiangiogenic therapies in ovarian cancer

Alexander Reinthaller

original report

Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia

Georgi Mihaylov, Zhasmina Mihaylova, Lubos Drgona, Andrea Cipkova, Jan Novak, Roumyana Petrova

Jul 16

Ausgabe: Sonderheft 3/2016

Report from the ASCO 2016 Congress, Chicago, 3rd-7th June, 2016

Dez 16

Ausgabe: 4/2016

Aktuelle Ausgaben

memo - Magazine of European Medical Oncology 1/2024
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
memo - Magazine of European Medical Oncology 1/2024
memo - Magazine of European Medical Oncology 8/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress
memo - Magazine of European Medical Oncology 9/2023
A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna
memo - Magazine of European Medical Oncology 4/2023
memo - Magazine of European Medical Oncology 10/2023
A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA
memo - Magazine of European Medical Oncology 11/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain
memo - Magazine of European Medical Oncology 12/2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023
memo - Magazine of European Medical Oncology 3/2023
memo - Magazine of European Medical Oncology 7/2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd-6th June 2023, European Hematology Association (EHA) 2023 Congress (hybrid), 8th-11th June 2023, and the 17th International Conference on Malignant Lymphoma (ICML) 2023 Congress (hybrid), 13th-17th June 2023

Scrollen für mehr

Benutzen Sie die Pfeiltasten für mehr

Scrollen oder Pfeiltasten für mehr

Springer Medizin Österreich

memo - Magazine of European Medical Oncology

Ausgabe 3/2016

Inhalt (13 Artikel)

Welcome to the new associate Editor-in-Chief of memo

A welcome statement from the associate Editor-in-Chief

ASH 2015—insights and outlooks

Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma

Novel strategies in the management of chronic lymphocytic leukemia (CLL)

Acute myeloid leukemia: highlights from ASH 2015

Indolent lymphoma at ASH 2015: new treatment approaches

Practice changing information in aggressive lymphoma, ASH 2015

Focus on multiple myeloma at ASH 2015

Reversal of direct oral anticoagulants in hemophilia treatment

ASH 2015 – stem cell transplantation

Antiangiogenic therapies in ovarian cancer

Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia

Aktuelle Ausgaben

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

memo - Magazine of European Medical Oncology 1/2024

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress

A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna

memo - Magazine of European Medical Oncology 4/2023

A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023

memo - Magazine of European Medical Oncology 3/2023